ALT ÜNİTE BAZLI AŞILARIN PULMONER UYGULAMASINA GENEL BAKIŞ

Kaynakça (1)

1. T.C. Sağlık Bakanlığı Web site. (2018). Retrieved 22 July, 2020, https://asi.saglik.gov.tr/genel bilgiler/41-asi-turleri.html 2. Dinc, G., Ulman, Y.I. (2007). The introduction of variolation “A La Turca” to the West by Lady Mary Montagu and Turkey’s contribution to this. Vaccine, 25 (21), 4261-4265. 3. Rappuoli, R. (2007). Bridging the knowledge gaps in vaccine design. Nature Biotechnology, 25, 1361-1366. 4. Clem, A.S. (2011). Fundamentals of vaccine immunology. Journal of Global Infectious Disease, 3, 73-78. 5. Wellington, K., Goa, K.L. (2003). Measles, mumps, rubella vaccine (PriorixTM; GSK-MMR): A review of its use in the prevention of measles, mumps and rubella. Drugs, 63, 2107-2126. 6. Kallerup, R.S., Foged, C. (2015). Classification of Vaccines. In: Foged C, Rades T, Perrie Y, Hook S, (Eds), Subunit Vaccine Delivery, (p.15). New York: Springer Science and Business Media. 7. Ferran, M.C., Skuse, G.R. (2017). Generation and Production of Modified Vaccinia Virus Ankara (MVA) as Vaccine Vector. In: Pavot V, Sebastian S, Turner V. A, Matthews J, Gilbert C.S (Eds), Recombinant Virus Vaccines, (pp. 97-119). New York: Springer Science and Business Media. 8. Van den Berg, J.H., Nuijen, B., Schumacher N.T., Haanen, B.A.G.J., Storm, G., Beijnen, H.J., Hennink, E.W. (2010). Synthetic vehicles for DNA vaccination. Journal of Drug Targeting, 18, 1-14. 9. Bins, A.D., van den Berg, J.H., Oosterhuis, K., Haanen, J.B.A.G. (2013). Recent advances towards the clinical application of DNA vaccines. Netherlands Journal of Medicine, 71, 109-117. 10. Powell, M.F., Newman, M.J. (1994). İmmunological and formulation design considerations for subunit vaccines. In: Powell, M.F., Newman, M.J. (Eds), Vaccine Design: The Subunit and Adjuvant Approach, (p.1). New York: Springer Science and Business Media. 11. Nevagi, R.J., Skwarczynski, M., Toth, I. (2019). Polymers for subunit vaccine delivery. European Polymer Journal, 114, 397-410. 12. O’Hagan, D.T., Friedland, L.R., Hanon, E., Didierlaurent, A.M. (2017). Towards an evidence based approach for the development of adjuvanted vaccines. Current Opinion in Immunology, 47, 93-102. 13. Foged, C. (2011). Subunit vaccines of the future: The need for safe, customized and optimized particulate delivery systems. Therapeutic Delivery, 2 (8), 1057-1077. 14. Bozkır, A., Hayta, G. (2004). Preparation and evaluation of multiple emülsions water-in-oil-in water (w/o/w) as deliver system for influenza virus antigens. Journal of Drug Targeting, 12